IPO

Cava prices IPO at $22 per share, above stated range
The Cava logo is displayed at a Cava location in Pasadena, California, Feb. 6, 2023. Mario Tama | Getty Images News | Getty Images Mediterranean fast-casual restaurant chain Cava priced its initial public offering at $22 per share, above a previously stated range, the company said Wednesday. Cava said it sold 14.4 million shares, which […]
Read More
Chip huge Arm snubbed London for a NY listing. But the London Inventory Exchange has not specified up hope
Guests appear out to St. Paul’s Cathedral from a rooftop in the City of London, United kingdom, on Thursday, March 2, 2023. Bloomberg | Bloomberg | Getty Images British tech darling Arm may be ditching its home turf in favor of New York for its remarkably-anticipated first community providing — but the CEO of the […]
Read More
Citigroup to spin off its Mexico enterprise by means of IPO
Critical Factors Citigroup announced Wednesday it ideas to go after an initial public featuring of its Mexico business, Banamex, generating official a long-telegraphed spinoff. Supply
Read More
Mediterranean restaurant chain Cava files for IPO as revenue climbs
A person walks past a Cava restaurant location in Pasadena, California, February 6, 2023. Mario Tama | Getty Images Mediterranean restaurant chain Cava saw its revenue rise 12.8% in 2022, according to regulatory filings released Friday as it filed to go public through an initial public offering. It plans to trade on the New York […]
Read More
Kenvue CEO looks to brand, product innovation to drive growth after IPO
Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson consumer-health business, speaks during an interview with CNBC during his company’s IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan McDermid | Reuters Kenvue CEO Thibaut Mongon is betting on brand and product innovation to drive growth at the newly spun-out company […]
Read More
Johnson & Johnson’s consumer health unit Kenvue started trading. What it means for J&J shareholders like us
Johnson & Johnson ‘s (JNJ) consumer-health unit Kenvue (KVUE) soared more than 22% on its first day of trading Thursday, bringing the Club holding one step closer to completing its business separation. The planned split, which is set for later this year, is in the best interest of shareholders of both the soon-to-be-solo Kenvue operations […]
Read More
J&J’s consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut
Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson‘s consumer health spinoff Kenvue jumped 16% in its market debut on […]
Read More
J&J’s consumer health business Kenvue is going public this week. Here’s what to know
Johnson & Johnson products on a shelf in a store in New York. Lucas Jackson | Reuters Johnson & Johnson‘s consumer health business, Kenvue, is expected to go public this week in the largest U.S. IPO in more than a year. That business is chock full of household names familiar to investors and the larger […]
Read More
Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says
Johnson & Johnson logo SOPA Images | LightRocket | Getty Images Johnson & Johnson‘s consumer health business is valued at $40 billion ahead of its initial public offering later this year, according to a report by The Wall Street Journal. The soon-to-be spinoff Kenvue aims to raise $3.5 billion or more in the offering, people […]
Read More